134509 - Fertility drugs and cancer.pdf (2.12 MB)
Fertility drugs and cancer
The short-term risks of fertility drug treatment, such as ovarian hyperstimulation syndrome, are well recognised by clinicians providing infertility treatment. There is uncertainty, however, about whether there are any longterm risks such as an increased risk of breast or gynaecological cancer. The possibility of such long-term risks is sometimes a concern for couples who are considering or receiving infertility treatment and their concerns need to be discussed using the best available evidence. The need for appropriate evaluation of long-term health effects of treatment with fertility drugs, including cancer, has been highlighted in major reviews of infertility treatments in Australia and Canada.
History
Publication title
Reproductive Medicine ReviewVolume
6Pagination
185-198ISSN
0962-2799Department/School
Menzies Institute for Medical ResearchPublisher
Cambridge University PressPlace of publication
United KingdomRights statement
Copyright 1997 Cambridge University PressRepository Status
- Open